Presentation was good I thought. Important not to get to ahead...

Presentation was good I thought. Important not to get to ahead of oneself though. Opthea had a great phase two and unsuccessful phase three. PTX results phase were excellent but derived from 11 patients. Results will need repeating over many more patients. I take comfort in the fact that the expert in America is very confident with PTX-100. We should know in 9-12 months as results should be relatively clear as to whether the same outcomes were achieved in the phase 2 trail. This is when there will be a potential significant rerate. Fingers crossed.
regards,
Bill